The lncRNA H19/miR-29b-3p/PGRN axis promotes EMT in CRC and counts a great deal for seeking appropriate diagnostic biomarkers and therapeutic targets for CRC [11]. This evidence concerns the gene H19 and colorectal carcinoma.